Introducing tissue profiling on Guardant Infinity
 
This week's BioPharma Dive brought to you by
 
 
Introducing tissue profiling on Guardant Infinity™
Low tissue sample input. Breakthrough multiomic insights.1
Tissue availability has always been a challenge in tissue-based CGP testing. In a real-world CGP tissue availability assessment, more than 50% of samples did not meet the recommended surface area of 25 mm2.2
Tissue profiling on Guardant Infinity can help you maximize results from precious tissue samples with significantly less input.1
Guardant Infinity
Only 6 slides required for NGS testing
Industry standard
~10 slides required for NGS testing3-5
Do more with less
With tissue profiling on Guardant Infinity, you get a comprehensive testing platform for liquid and tissue profiling plus ctDNA monitoring and real-world data solutions to help build a customized clinical development and CDx strategy that meets challenging timelines and needs.
Streamline tissue and liquid testing with a single, trusted CDx partner. Guardant Health can help:
Streamline your tissue profiling with comprehensive, multiomic analysis—including genomic, epigenomic, and RNA-fusion data—on the Guardant Infinity platform1
Position your program for success with the established regulatory expertise and broad commercial reach of a global CDx partner
Streamline your clinical development program with one technology platform from a leading precision oncology partner.
Connect with us now
CDx, companion diagnostic; CGP, comprehensive genomic profiling; NGS, next-generation sequencing.

References: 1. Guardant Health data on file. 2025. Guardant Health, Inc. Redwood City, CA. 2. Tomlins SA, Hovelson DH, Suga JM, et al. Real-world performance of a comprehensive genomic profiling optimized for small tumor samples. JCO Precis Oncol. 2021;5:1312-1324. doi:10.1200/PO.20.00472 3. Tempus Life Sciences Specimen Guidelines. 2022. Tempus Life Sciences. Chicago, IL. 4. Caris Life Sciences Specimen Preparation Instructions. 2019. Caris MPI, Inc. Phoenix, AZ. 5. Foundation Medicine Specimen Instructions. 2024. Foundation Medicine, Inc. Boston, MA.
Guardant Health, Inc.
3100 Hanover Street
Palo Alto, CA 94304

© 2025 Guardant Health, Inc.
All rights reserved.
 

Want to reach 108,000+ biopharma executives with your own message? Get the media kit or contact us directly at advertising@industrydive.com.

About this email: You are receiving this message as part of your complimentary newsletter subscription to BioPharma Dive. If you no longer wish to receive the daily newsletter, you can switch to a weekly subscription or unsubscribe. See our full privacy policy. BioPharma Dive is a product of TechTarget, Inc. and its subsidiaries, 275 Grove St. Newton, MA, 02466